课题基金 / 基金详情

NHLBI CLINICAL INVESTIGATOR AWARD PROGRAM

NHLBI CLINICAL INVESTIGATOR AWARD PROGRAM
NHLBI 临床研究者奖励计划
批准号:
3081839
负责人:
DIANA S BEARDSLEY
金额:
$6.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1988-06-30

项目摘要

项目成果

DIANA S BEARDSLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immune mediated platelet destruction occurs in idiopathic (immune) thrombocytopenia purpura (ITP), post transition purpura (PTP), neonatal isoimmune thrombocytopenia (NITP), and in other disease states. The antigens and antibodies involved in these conditions are not well characterized. Using techniques we have developed for identifying antigen bearing proteins of platelets, we will study the nature and structure of these platelet antigens and the antibodies which mediate platelet destruction. The technique involves electrophoretic separation of platelet membrane proteins, transfer to nitrocellulose paper, exposure to antibody, and detection of antibody binding using a radiolabeled second antibody. We propose to further characterize the PLA1 platelet antigen and to study the nature of the anti PLA1 antibodies in NITP. We will attempt to identify the platelet Fc receptor or Fab binding site to which platelet associated IgG may bind. Finally, we will further characterize the antigens and antibodies we have identified in a subject of children with ITP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NHLBI CLINICAL INVESTIGATOR AWARD PROGRAM
  • 批准号:
    3081841
  • 项目类别:
  • 资助金额:
    $6.26万
  • 财政年份:
    1986
  • 负责人:
    DIANA S BEARDSLEY
  • 依托单位:
ROLE OF PLATELET SPECIFIC ANTIGENS IN TRANSFUSION
  • 批准号:
    3354877
  • 项目类别:
  • 资助金额:
    $8.41万
  • 财政年份:
    1986
  • 负责人:
    DIANA S BEARDSLEY
  • 依托单位:
ROLE OF PLATELET SPECIFIC ANTIGENS IN TRANSFUSION
  • 批准号:
    3354876
  • 项目类别:
  • 资助金额:
    $9.05万
  • 财政年份:
    1986
  • 负责人:
    DIANA S BEARDSLEY
  • 依托单位:
NHLBI CLINICAL INVESTIGATOR AWARD PROGRAM
  • 批准号:
    3081842
  • 项目类别:
  • 资助金额:
    $5.68万
  • 财政年份:
    1986
  • 负责人:
    DIANA S BEARDSLEY
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究